EU drug regulator evaluating Pfizer vaccine for youngsters
May 3, 2021
FacebookTwitterEmail
A volunteer vaccinator prepares to administer a dose of the Pfizer coronavirus vaccine at a vaccine centre in the Swaminarayan School in Neasden, north London, Saturday, May 1, 2021.Matt Dunham/AP
AMSTERDAM (AP) — The European Union's drug regulator said Monday it has begun evaluating a request by Pfizer Inc. and BioNTech to extend approval of their coronavirus vaccine to include children ranging in age from 12 to 15.
The European Medicines Agency's human medicines committee will carry out an accelerated assessment of data submitted by Pfizer and BioNTech and is expected to reach a decision in June, unless it requires extra information, the agency said.